Inactive Instrument

Alexza Pharmaceuticals, Inc. Stock Nasdaq

Stocks

End-of-day quote Nasdaq
- ^USD	-

16-03-28	Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	PU
16-03-15	Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	PU
16-03-09	Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	PU
16-02-26	Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	PU
16-02-24	Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	PU

15-12-22	Alexza Pharmaceuticals : Les valeurs à suivre sur les marchés américains
15-12-22	USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Mario Rovirosa Escosura CEO	Chief Executive Officer	-	-
Stacy Palermini DFI	Director of Finance/CFO	-	2002-12-31
Wolfgang Schmidt PRN	Corporate Officer/Principal	-	2019-04-30

Director	Title	Age	Since
Jorge Ramentol Massana BRD	Director/Board Member	-	2016-06-20
Sergio Ferrer-Salat Serra di Migni BRD	Director/Board Member	-	2016-06-20
Joan Fanés Trillo BRD	Director/Board Member	-	2016-06-20

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+10.00%	+4.50%	+58.63%	+71.20%	66.87B
LONZA GROUP AG	+1.65%	+4.93%	+24.89%	+102.90%	56.55B
ARGENX SE	+1.64%	+3.03%	+14.57%	+79.47%	57.2B
IQVIA HOLDINGS INC.	+0.46%	-5.47%	+25.04%	+33.77%	43.47B
REVOLUTION MEDICINES, INC.	+2.82%	+5.82%	+240.96%	+801.17%	42.8B
BEONE MEDICINES AG	+6.42%	+1.18%	+22.18%	+105.56%	42.95B
GENMAB A/S	+3.40%	-2.11%	+101.63%	+85.21%	32.11B
CELLTRION, INC.	+5.32%	+5.37%	+19.12%	+52.98%	34.01B
INSMED INCORPORATED	+5.32%	+13.43%	-39.82%	+342.66%	24.13B
Average	+4.39%	+2.73%	+51.91%	+186.10%	44.45B
Weighted average by Cap.	+4.50%	+2.58%	+53.66%	+170.53%

Employees

Sector